Terran Biosciences, Inc.: Terran Biosciences and University of Maryland, Baltimore announce exclusive licensing deal for a portfolio of patents and data supporting novel innovation in the psychedelic therapeutic space
NEW YORK, March 8, 2022 /PRNewswire/ -- Terran Biosciences, Inc. ("Terran") has entered into an agreement with the University of Maryland, Baltimore ("UMB") for a worldwide exclusive license
Source: finanznachrichten.de
